𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cholinesterase inhibitors in Alzheimer's disease

✍ Scribed by Roger Bullock

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
31 KB
Volume
16
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hypertension, white matter change and re
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
✍ Peter J. Connelly; Neil P. Prentice; Kenneth G. Fowler πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 1 views

Background Cholinesterase inhibitors are used to treat mild to moderate Alzheimer's disease. Their role in patients with concurrent cerebrovascular disease has been less well studied, and the influence of vascular risk factors on response to treatment is uncertain. We investigated the effect of hype

Review of drug development and therapeut
Review of drug development and therapeutic role of cholinesterase inhibitors in Alzheimer's disease
✍ John J. Sramek; Victoria Zarotsky; Neal R. Cutler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract Researchers have for some time appreciated the role of the neurotransmitter acetylcholine in Alzheimer's disease, and have realized the development of a number of acetylcholinesterase inhibitors. Bridging and dynabridging studies have played an important role in the development of these

A randomised double-blind placebo-contro
A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease
✍ Peter J. Connelly; Neil P. Prentice; Gary Cousland; Jim Bonham πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

## Abstract ## Objectives (1) to assess the effect of 1 mg folic acid supplementation of cholinesterase inhibitors (ChI) in a 6 month double‐blind placebo‐controlled study of patients with Alzheimer's Disease (AD) and (2) to assess whether outcome measures were affected by changes in homocysteine